166 related articles for article (PubMed ID: 33044738)
1. Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.
Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; España-Gregori E; Casanova B
Acta Neurol Belg; 2021 Dec; 121(6):1767-1775. PubMed ID: 33044738
[TBL] [Abstract][Full Text] [Related]
2. Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis.
Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; Carreres-Polo J; España-Gregori E; Casanova B
Eur Neurol; 2022; 85(2):112-121. PubMed ID: 34788755
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks.
Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; Carreres-Polo J; España-Gregori E; Casanova B
J Neurol Sci; 2020 Dec; 419():117180. PubMed ID: 33091751
[TBL] [Abstract][Full Text] [Related]
4. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.
Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I
Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530
[TBL] [Abstract][Full Text] [Related]
5. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): A systematic review and meta-analysis.
Mirmosayyeb O; Yazdan Panah M; Mokary Y; Ghaffary EM; Ghoshouni H; Zivadinov R; Weinstock-Guttman B; Jakimovski D
J Neurol Sci; 2023 Nov; 454():120847. PubMed ID: 37924591
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
[TBL] [Abstract][Full Text] [Related]
9. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis.
Jakimovski D; Zivadinov R; Vaughn CB; Ozel O; Weinstock-Guttman B
J Neurol Sci; 2021 Aug; 427():117552. PubMed ID: 34175775
[TBL] [Abstract][Full Text] [Related]
11. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.
Bsteh G; Hegen H; Teuchner B; Amprosi M; Berek K; Ladstätter F; Wurth S; Auer M; Di Pauli F; Deisenhammer F; Berger T
Mult Scler; 2019 Feb; 25(2):196-203. PubMed ID: 29095097
[TBL] [Abstract][Full Text] [Related]
12. Predictors of vision impairment in Multiple Sclerosis.
Sanchez-Dalmau B; Martinez-Lapiscina EH; Pulido-Valdeolivas I; Zubizarreta I; Llufriu S; Blanco Y; Sola-Valls N; Sepulveda M; Guerrero A; Alba S; Andorra M; Camos A; Sanchez-Vela L; Alfonso V; Saiz A; Villoslada P
PLoS One; 2018; 13(4):e0195856. PubMed ID: 29664921
[TBL] [Abstract][Full Text] [Related]
13. Color vision impairment in multiple sclerosis points to retinal ganglion cell damage.
Lampert EJ; Andorra M; Torres-Torres R; Ortiz-Pérez S; Llufriu S; Sepúlveda M; Sola N; Saiz A; Sánchez-Dalmau B; Villoslada P; Martínez-Lapiscina EH
J Neurol; 2015 Nov; 262(11):2491-7. PubMed ID: 26259563
[TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disability.
Vidal-Jordana A; Pareto D; Cabello S; Alberich M; Rio J; Tintore M; Auger C; Montalban X; Rovira A; Sastre-Garriga J
Eur J Neurol; 2020 Nov; 27(11):2225-2232. PubMed ID: 32602573
[TBL] [Abstract][Full Text] [Related]
15. OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
Chen JJ; Sotirchos ES; Henderson AD; Vasileiou ES; Flanagan EP; Bhatti MT; Jamali S; Eggenberger ER; Dinome M; Frohman LP; Arnold AC; Bonelli L; Seleme N; Mejia-Vergara AJ; Moss HE; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Hellmann MA; Hodge D; Oertel FC; Paul F; Saidha S; Calabresi PA; Pittock SJ
Mult Scler Relat Disord; 2022 Feb; 58():103525. PubMed ID: 35038647
[TBL] [Abstract][Full Text] [Related]
16. Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis.
Birkeldh U; Manouchehrinia A; Hietala MA; Hillert J; Olsson T; Piehl F; Kockum I; Brundin L; Zahavi O; Wahlberg-Ramsay M; Brautaset R; Nilsson M
Mult Scler Relat Disord; 2019 Nov; 36():101414. PubMed ID: 31574404
[TBL] [Abstract][Full Text] [Related]
17. Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.
Oh J; Sotirchos ES; Saidha S; Whetstone A; Chen M; Newsome SD; Zackowski K; Balcer LJ; Frohman E; Prince J; Diener-West M; Reich DS; Calabresi PA
Neurology; 2015 Feb; 84(7):720-8. PubMed ID: 25609766
[TBL] [Abstract][Full Text] [Related]
18. Associations of optical coherence tomography with disability and brain MRI volumetry in patients with multiple sclerosis.
Skirková M; Mikula P; Maretta M; Fedičová M; Vitková M; Frigová L; Szilasi J; Moravská M; Horňák M; Szilasiová J
Neurol Neurochir Pol; 2022; 56(4):326-332. PubMed ID: 35289383
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis.
Ganapathy Subramanian R; Zivadinov R; Bergsland N; Dwyer MG; Weinstock-Guttman B; Jakimovski D
J Neurol; 2023 Aug; 270(8):3758-3769. PubMed ID: 37067590
[TBL] [Abstract][Full Text] [Related]
20. Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
Felgueiras H; Parra J; Cruz S; Pereira P; Santos AF; Rua A; Meira D; Fonseca P; Pedrosa C; Cardoso JN; Almeida C; Araújo M; Santos E
J Neuroophthalmol; 2016 Sep; 36(3):275-9. PubMed ID: 27261948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
